+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Insmed Inc (INSM) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 55 Pages
  • May 2023
  • GlobalData
  • ID: 1292039
Insmed Inc (INSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Insmed Inc (Insmed) is a biopharmaceutical company that focuses on developing novel therapeutics for rare diseases. Its marketed product, Arikayce (liposomal amikacin for inhalation) is indicated for mycobacterium avium complex (MAC) lung infection and NTM lung infections caused by MAC in adult patients. The company uses its proprietary, liposomal technology to develop its novel drug candidates. Its pipeline products include brensocatib for non-cystic fibrosis (non-CF) bronchiectasis, cystic fibrosis and COVID-19; TPIP, an inhaled formulation of a treprostinil prodrug for pulmonary arterial hypertension (PAH), idiopathic pulmonary fibrosis, and PAH associated with interstitial lung diseases. The company operates in the US, the UK, the Netherlands, Ireland, Germany, Italy, France and Japan through its subsidiaries. Insmed is headquartered in Bridgewater, New Jersey, the US.

Insmed Inc Key Recent Developments

May 08, 2023: Insmed unveils new research platforms and capabilities at investor and analyst event, "The future of rare at Insmed: Functional genes, AI-enhanced proteins, glowing algae, and more"
May 04, 2023: Insmed reports first quarter 2023 financial results and provides business update
Feb 23, 2023: Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Feb 09, 2023: Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Insmed Inc - Key Facts
  • Insmed Inc - Key Employees
  • Insmed Inc - Key Employee Biographies
  • Insmed Inc - Major Products and Services
  • Insmed Inc - History
  • Insmed Inc - Company Statement
  • Insmed Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Insmed Inc - Business Description
  • Geographical Segment: Europe and Rest of World
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: The U.S
  • Performance
  • R&D Overview
  • Insmed Inc - Corporate Strategy
  • Insmed Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Insmed Inc - Strengths
  • Insmed Inc - Weaknesses
  • Insmed Inc - Opportunities
  • Insmed Inc - Threats
  • Insmed Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Insmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Insmed Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Insmed Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 08, 2023: Insmed unveils new research platforms and capabilities at investor and analyst event,"The future of rare at Insmed: Functional genes, AI-enhanced proteins, glowing algae, and more"
  • May 04, 2023: Insmed reports first quarter 2023 financial results and provides business update
  • Feb 23, 2023: Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
  • Feb 09, 2023: Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023
  • Oct 27, 2022: Insmed Reports Third Quarter 2022 Financial Results and Provides Business Update
  • Aug 04, 2022: Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update
  • Jul 22, 2022: Insmed to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022
  • May 23, 2022: Insmed Names Drayton Wise Chief Commercial Officer
  • May 05, 2022: Insmed Reports First Quarter 2022 Financial Results and Provides Business Update
  • Mar 28, 2022: Insmed to showcase new data across three pillars at the American Thoracic Society 2022 International Conference
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Insmed Inc, Key Facts
  • Insmed Inc, Key Employees
  • Insmed Inc, Key Employee Biographies
  • Insmed Inc, Major Products and Services
  • Insmed Inc, History
  • Insmed Inc, Subsidiaries
  • Insmed Inc, Key Competitors
  • Insmed Inc, Ratios based on current share price
  • Insmed Inc, Annual Ratios
  • Insmed Inc, Interim Ratios
  • Insmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Insmed Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Insmed Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Insmed Inc, Performance Chart (2018 - 2022)
  • Insmed Inc, Ratio Charts
  • Insmed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Insmed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Vertex Pharmaceuticals Inc
  • Gilead Sciences Inc
  • Alfresa Pharma Corp
  • ContraFect Corp
  • Chiesi SA
  • Laurent Pharmaceuticals Inc
  • Teva Pharmaceuticals USA Inc
  • ContraFect Corp
  • Chiesi SA
  • Alfresa Pharma Corp
  • Laurent Pharmaceuticals Inc
  • Teva Pharmaceuticals USA Inc
  • Vertex Pharmaceuticals Inc
  • Gilead Sciences Inc